Literature DB >> 19869778

IMMUNITY TO POLIOMYELITIS IN MOTHERS AND THE NEWBORN AS SHOWN BY THE NEUTRALIZATION TEST.

W L Aycock1, S D Kramer.   

Abstract

Neutralization tests for the virus of poliomyelitis on blood serum of urban mothers and their newborn infants showed that immunity was present in ten out of twelve (83 per cent) infants and in ten out of twelve (83 per cent) mothers, with a complete correspondence between mother and infant. These tests point to passive transmission of immunity from mother to infant. Previous tests on other children (1 to 5 years) indicate that immunity in infants is transitory. Previous observations concerning the extent of immunity in urban adults are confirmed and extended. The results of these tests are in accord with the age distribution of poliomyelitis and parallel corresponding observations in diphtheria.

Entities:  

Year:  1930        PMID: 19869778      PMCID: PMC2131894          DOI: 10.1084/jem.52.4.457

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  [On the diaplacental transmission of neutralizing antibodies of poliomyelitis viruses].

Authors:  E GIBBELS; W SCHEID; R ACKERMANN
Journal:  Arch Gesamte Virusforsch       Date:  1960

2.  Human antibodies can cross guinea pig placenta and bind its neonatal Fc Receptor: implications for studying immune prophylaxis and therapy during pregnancy.

Authors:  Evi Budo Struble; Li Ma; Lilin Zhong; A Lesher; Joel Beren; Pei Zhang
Journal:  Clin Dev Immunol       Date:  2012-09-09

3.  THE NEUTRALIZATION TEST IN POLIOMYELITIS : COMPARATIVE RESULTS WITH FOUR STRAINS OF THE VIRUS.

Authors:  J R Paul; J D Trask
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307

4.  Immunological reactions of the Coxsackie viruses. III. Cross-protection tests in infant mice born of vaccinated mothers; transfer of immunity through the milk.

Authors:  J L MELNICK; N A CLARKE; L M KRAFT
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.